Promentis Pharmaceuticals Lands $8,787,399 New Round

Feed Type
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=be4c8573-5610-4bc2-8266-07963a4488b5
Date
10/6/2016
Company Name
Promentis Pharmaceuticals
Mailing Address
826 N. Plankinton Ave. Milwaukee, WI 53203 USA
Company Description
Promentis Pharmaceuticals, Inc. is a pharmaceutical company developing novel compounds for the treatment of schizophrenia and other central nervous system disorders.
Website
http://www.promentispharma.com
Transaction Type
Venture Equity
Transaction Amount
$8,787,399
Transaction Round
Undisclosed
Proceeds Purposes
Proceeds purposes were not disclosed. 8 investors participated in the offering. The amount may include options, warrants or other securities. Contact technology company for investment details, if applicable. Not an offer or solicitation for the sale of securities or debt. SEC regulatory filing.
M&A Terms
Venture Investor
Undisclosed